Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE006447 |
ID: | TCMBANKHE006447 |
植物拉丁名: |
|
功能与主治: | To regulate menstruation and stanch bleeding, dissipate stasis and relieve pain, resolve toxin and disperse swelling./Blood ejection, hemoptysis, spontaneous external bleeding, hematochezia, flooding and spotting, bleeding due to external injury, menstrual disorder, postpartum galactostasis, knocks and falls, pain in joints due to rheumatalgia, swelling toxin of sore and boil, poisonous snake bite. |
药用植物名: | 小连翘 |
药用部位: | whole herb |
TCM_ID_id: | 5890 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN000044 | hypericin | 4,5,7,4',5',7'-Hexahydroxy-2,2'-dimethylnaphthodianthrone; (component of) Hypericum spp (st. John's wort); Cyclosan; 1,3,4,6,8,13-Hexahydroxy-10,11-dimethylphenanthro [1,10,9,8-opqra]perylene-7,14-dione P-conformer; NSC 407313; Hypericin & Visible light; NCGC00162454-01; Cyclo werrol; NCI60_006799; VIMRxyn; InChI=1/C30H16O8/c1-7-3-9(31)19-23-15(7)16-8(2)4-10(32)20-24(16)28-26-18(12(34)6-14(36)22(26)30(20)38)17-11(33)5-13(35)21(29(19)37)25(17)27(23)28/h3-6,31-36H,1-2H; AIDS052002; Hypericum Extract; Cyclo-Werol; 56690_FLUKA; phenanthro[1,10,9,8-opqra]perylene-7,14-dione, 1,3,4,6,8,13-hexahydroxy-10,11-dimethyl-; HSCI1_000202; C07606; NCGC00163378-01; 4,5,7,4',5',7'-Hexahydroxy-2,2'-dimethyl-mesonapthtodianthron; NSC 622946; AIDS000117; AIDS-052002; NSC622946; Hypericum red; Hypericin from Hypericum perforatum; NCI60_003879; DRG-0113; EINECS 208-941-0; 548-04-9; 1,3,4,6,8,13-hexahydroxy-10,11-dimethylphenanthro[1,10,9,8-opqra]perylene-7,14-dione; LMPK02000026; Phenanthro[1,10,9,8-opqra]perylene-7,14-dione,1,3,4,6,8,13-hexahydroxy-10,11-dimethyl-, stereoisomer; BiomolKI_000032; NSC407313; 1,3,4,6,8,13-Hexahydroxy-10,11-dimethylphenanthro(1,10,9,8-opqra)perylene-7,14-dione; BiomolKI2_000040; AIDS-000117; Hypericin | C30H16O8 | 504.44 | CC1=CC(=O)C2=C(C3=C(C=C(C4=C3C5=C2C1=C6C(=CC(=O)C7=C(C8=C(C=C(C4=C8C5=C67)O)O)O)C)O)O)O |
| TCMBANKIN036847 | hyperforin | (1R,5R,7S,8R)-4-hydroxy-8-methyl-3,5,7-tris(3-methylbut-2-enyl)-8-(4-methylpent-3-enyl)-1-(2-methylpropanoyl)bicyclo[3.3.1]non-3-ene-2,9-dione; C07608; Hyperforin; PDSP2_001346; 11079-53-1; (1R,5R,7S,8R)-4-hydroxy-8-methyl-3,5,7-tris(3-methylbut-2-enyl)-1-(2-methyl-1-oxopropyl)-8-(4-methylpent-3-enyl)bicyclo[3.3.1]non-3-ene-2,9-dione; Spectrum5_002025; NCGC00163120-01; hyperforin ; (1R,5R,7S,8R)-4-hydroxy-1-isobutyryl-8-methyl-3,5,7-tris(3-methylbut-2-enyl)-8-(4-methylpent-3-enyl)bicyclo[3.3.1]non-3-ene-2,9-quinone | C36H54O4 | 551 | C1(O[H])=C(C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])C(=O)[C@@]([C@@](C([H])([H])C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])(C([H])([H])[H])[C@@]([H])(C([H])([H])\C([H])=C(/C([H]) ([H])[H])\C([H])([H])[H])C([H])([H])C2([H])[H])(C(=O)C([H])(C([H])([H])[H])C([H])([H])[H])C(=O)[C@@]12C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H] |
| TCMBANKIN036935 | otogirin | C21H30O4 | 346.5 g/mol | CC1=C(C=C(C(=C1O)C(=O)C(C)C)O)OCC=C(C)CCC=C(C)C | |
| TCMBANKIN041138 | Erectquione A | 344.4 g/mol | |||
| TCMBANKIN047318 | Erectquione B | 484.6 g/mol | |||
| TCMBANKIN049358 | otogirone | C23H34O5 | |||
| TCMBANKIN049689 | Erectquione C | 430.5 g/mol | |||
| TCMBANKIN058090 | demethylwedelolactone | 3,5,13,14-tetrahydroxy-8,17-dioxatetracyclo[8.7.0.0(2),.0(1)(1),(1)]heptadeca-1(10),2,4,6,11(16),12,14-heptaen-9-one; C15H8O7; KB-216382; AKOS015897135; desmethylwedelolactone; MolPort-005-945-584; I07-0296; 1,3,8,9-Tetrahydroxy-6H-benzofuro[3,2-c]chromen-6-one; AC1NURC5; FT-0698755; 468D559; 4CH-024768; Demethylwedelolactone; CHEMBL2089002; DTXSID00214968; 3,5,13,14-TETRAHYDROXY-8,17-DIOXATETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-1(10),2(7),3,5,11(16),12,14-HEPTAEN-9-ONE; Norwedelolactone; 6468-55-9; AJ-65335; BG01013426; demethyl wedelolactone; ZINC14726530; ST24036753; AX8245784; 6H-Benzofuro(3,2-c)(1)benzopyran-6-one, 1,3,8,9-tetrahydroxy-; 1,3,8,9-tetrahydroxy-[1]benzofuro[3,2-c]chromen-6-one; 1,3,8,9-Tetrahydroxy-6H-benzofuro-[3,2-c]chromen-6-one; SCHEMBL3364302; LMPK12090041; 1,3,8,9-Tetrahydroxy-6H-benzofuro[3,2-c][1]benzopyran-6-one; 9902AB; AK120368;6H-Benzofuro(3,2-c)(1)benzopyran-6-one, 1,3,8,9-tetrahydroxy-; 6468-55-9; 1,3,8,9-tetrahydroxy-6-benzofurano[3,2-c]chromenone; 1,3,8,9-tetrahydroxy-[1]benzoxolo[3,2-c]chromen-6-one;desmethylwedelolactone;demethylwedelolacton;1,3,8,9-tetrahydroxybenzofurano[3,2-c]chromen-6-one | C15H8O7 | 300.22 | C1=C(C=C2C(=C1O)C3=C(C4=CC(=C(C=C4O3)O)O)C(=O)O2)O |
| TCMBANKIN058130 | quercetin-３-Ｏ-galactoside | hyperin; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one; SMR000466394; C10073; ACon1_000623; Quercetin 3-O-beta-D-galactopyranoside; Quercetin-3-O-galactoside;p Hyperin; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3-(beta-D-galactopyranosyloxy)-5,7-dihydroxy-; 482-36-0; Hyperin; Quercetin 3-galactoside; AIDS026341; Hyperasid; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-4-chromenone; NSC 407304; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-chromone; Quercetin-3-O-galactoside; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-chromen-4-one; Hyperozide; AIDS-026341; MLS000759538; Quercetin 3-D-galactoside; EINECS 207-580-6; Quercetin-3-galactoside; Hyperin (8CI); Hyperoside; 2-(3,4-Dihydroxyphenyl)-3-(beta-D-galactopyranosyloxy)-5,7-dihydroxy-4H-1-benzopyran-4-one; 83388_FLUKA; MEGxp0_000392; Hyperosid; Quercetin 3-beta-D-galactopyranoside | C21H19O12- | 463.4 g/mol | C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OC4C(C(C(C(O4)CO)O)O)O)O)[O-] |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab